# Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

> **NCT00366509** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 157 (actual)

## Conditions studied

- Pulmonary Disease
- Oropharyngeal Disease
- Lymphangioleiomyomatosis
- Pulmonary Fibrosis
- Asthma
- Sarcoidosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00366509
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-18
- **Primary completion:** 2016-01-01
- **Final completion:** 2016-10-27
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366509, "Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00366509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*